trial
as of 2026-07-01Study of Amantadine for Risperidone Consta or Paliperidone Treated Patients to Decrease Prolactin Elevation
NCTId NCT00975611
at a glance
Phase 4 · Terminated
Enrollment 6 (actual)
Sponsored by David C. Henderson, MD
Primary completion 2012-01
Synthesized from structured facts only — each point cited above.
Design & status
Phase
Phase 4
Status
Terminated
Enrollment
6 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Quadruple
Start
2009-10
Primary completion
2012-01
Eligibility
ALL · 18 Years · 65 Years
Interventions & indications
Sponsors
David C. Henderson, MDLead Sponsor
Ortho-McNeil Janssen Scientific Affairs, LLCCollaborator
Investigators
1
David J. Miklowitz, Ph.D.Principal Investigator
Sites
1 total
Boston, United States
Facts & assertions
4 sourced
Enrollment
6
Phase
PHASE4
Primary Completion Date
2012-01
Status
TERMINATED
relationships
The graph out of here
drug
lead_sponsor
company
collaborator
indication
investigator